Related Experiment Video
Updated: Jun 20, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL
Qiang Lu1, Chao Lu, Guo-Ping Zhou
1Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Objectives:
Bladder cancer is the most common type of urologic cancer in Chinese males. The 5-year survival rate of advanced bladder cancer is approximately 20%-40%. There is an obvious urgent need for novel and effective therapies against bladder cancer. MicroRNAs (miRNAs) are a recently discovered class of noncoding RNAs; suppressing miRNA-221 might prove beneficial in several cancers. To explore novel and effective therapies against bladder cancer, we explored the effects of miRNA-221 silencing on the survival of bladder cancer cells.
Materials And Methods:
Northern blot analysis was used to determine miRNA-221 expression levels in bladder cancer T24 cells, RT4 cells and human normal urothelial cells. miRNA-221 was silenced with antisense oligonucleotides in T24 cells and pro-apoptotic effect of necrosis factor related apoptosis-inducing ligand (TRAIL) on miRNA-221-silenced cells was assessed with flow cytometry. The p27(kip1) protein expression in miRNA-221-silenced cells exposed to TRAIL was detected by Western blotting. The role of miRNA-221 silencing on T24 cell cycle phase distribution was investigated through flow cytometric analysis.
Results:
Human miRNA-221 was significantly up-regulated in bladder cancer T24 cells and RT4 cells compared to human normal urothelial cells. T24 cell was TRAIL-resistant cell line. MiRNA-221 silencing predisposed T24 cells to undergo apoptosis induced by TRAIL and resulted in an up-modulation of cyclin-dependent kinase inhibitor p27Kip1. MiRNA-221 suppression promoted the activation of caspase 3 induced by TRAIL in T24 cells.
Conclusions:
MiRNA-221 silencing rendered human bladder cancer T24 cells to undergo apoptosis induced by TRAIL. Our findings suggest a potential role of suppressing miRNA-221 in human bladder cancer therapy.
Insights
Silencing microRNA-221 (miRNA-221) in bladder cancer cells increases their susceptibility to TRAIL-induced apoptosis. This suggests miRNA-221 suppression is a potential therapeutic strategy for bladder cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Bladder cancer presents a significant therapeutic challenge, particularly in advanced stages, with limited survival rates.
- MicroRNAs (miRNAs) are emerging as key regulators in cancer development, with specific miRNAs implicated in various malignancies.
- miRNA-221 has been identified as potentially oncogenic, warranting investigation into its role in bladder cancer.
Purpose of the Study:
- To investigate the therapeutic potential of silencing miRNA-221 in bladder cancer.
- To determine the effect of miRNA-221 suppression on the chemosensitivity of bladder cancer cells to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand).
Main Methods:
- Northern blot analysis was employed to quantify miRNA-221 expression in bladder cancer cell lines (T24, RT4) and normal urothelial cells.
- Antisense oligonucleotides were used to silence miRNA-221 in T24 cells.
- Flow cytometry assessed apoptosis induction by TRAIL in miRNA-221-silenced cells and analyzed cell cycle distribution.
- Western blotting detected p27(kip1) protein levels in response to TRAIL treatment in silenced cells.
Main Results:
- miRNA-221 was significantly upregulated in bladder cancer cells (T24, RT4) compared to normal urothelial cells.
- Silencing miRNA-221 sensitized TRAIL-resistant T24 bladder cancer cells to TRAIL-induced apoptosis.
- miRNA-221 suppression led to increased p27(kip1) protein levels and enhanced caspase-3 activation upon TRAIL treatment.
Conclusions:
- Silencing miRNA-221 enhances TRAIL-induced apoptosis in human bladder cancer T24 cells.
- These findings highlight the potential of miRNA-221 suppression as a novel therapeutic approach for bladder cancer treatment.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi